Boothbay Fund Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-50,000
| Closed | -$167K | – | 1390 |
|
|
2025
Q1 | $167K | Buy |
+50,000
| New | +$167K | ﹤0.01% | 1027 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1516 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1567 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1504 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1563 |
|
|
2022
Q1 | – | Sell |
-17,366
| Closed | -$332K | – | 2025 |
|
|
2021
Q4 | $332K | Sell |
17,366
-5,808
| -25% | -$111K | 0.01% | 1059 |
|
|
2021
Q3 | $571K | Sell |
23,174
-597
| -3% | -$14.7K | 0.02% | 839 |
|
|
2021
Q2 | $619K | Buy |
+23,771
| New | +$619K | 0.02% | 789 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1426 |
|
|
2017
Q3 | – | Sell |
-16,746
| Closed | -$123K | – | 601 |
|
|
2017
Q2 | $123K | Buy |
+16,746
| New | +$123K | 0.03% | 522 |
|